Log in

Joint Stock Forecast, Price & News

+0.45 (+2.60 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $17.75
50-Day Range
MA: $17.17
52-Week Range
Now: $17.75
Volume100,749 shs
Average Volume115,373 shs
Market Capitalization$248.70 million
P/E Ratio88.75
Dividend YieldN/A
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.
Read More
Joint logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.58 out of 5 stars

Industry, Sector and Symbol

Industry Patent owners & lessors
Current SymbolNASDAQ:JYNT



Sales & Book Value

Annual Sales$48.45 million
Cash Flow$0.38 per share
Book Value$0.41 per share


Net Income$3.32 million


Market Cap$248.70 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
+0.45 (+2.60 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive JYNT News and Ratings via Email

Sign-up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Joint (NASDAQ:JYNT) Frequently Asked Questions

How has Joint's stock been impacted by COVID-19 (Coronavirus)?

Joint's stock was trading at $13.61 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, JYNT stock has increased by 30.4% and is now trading at $17.75.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Joint?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Joint

When is Joint's next earnings date?

Joint is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Joint

How were Joint's earnings last quarter?

Joint Corp (NASDAQ:JYNT) announced its quarterly earnings results on Thursday, August, 6th. The company reported $0.01 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.06) by $0.07. The company earned $12.59 million during the quarter, compared to analyst estimates of $10.13 million. Joint had a return on equity of 47.43% and a net margin of 5.38%.
View Joint's earnings history

What price target have analysts set for JYNT?

4 brokerages have issued 12-month price objectives for Joint's stock. Their forecasts range from $20.00 to $24.00. On average, they anticipate Joint's share price to reach $21.75 in the next year. This suggests a possible upside of 22.5% from the stock's current price.
View analysts' price targets for Joint

Who are some of Joint's key competitors?

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), Aurora Cannabis (ACB), Adobe (ADBE), Mastercard (MA), NVIDIA (NVDA), Raytheon Technologies (RTX), salesforce.com (CRM), Lululemon Athletica (LULU), Okta (OKTA) and Starbucks (SBUX).

Who are Joint's key executives?

Joint's management team includes the following people:
  • Mr. Peter D. Holt, CEO, Pres & Director (Age 60)
  • Jake Singleton, Chief Financial Officer (Age 37)
  • Mr. Jorge Armenteros, VP of Operations
  • Dr. James Edwards, Chief Chiropractic & Compliance Officer
  • Mr. Craig P. Colmar, Sec. (Age 66)

When did Joint IPO?

(JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

What is Joint's stock symbol?

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Who are Joint's major shareholders?

Joint's stock is owned by many different retail and institutional investors. Top institutional shareholders include Skylands Capital LLC (5.30%), Goldman Sachs Group Inc. (3.21%), Wasatch Advisors Inc. (3.10%), Cadence Capital Management LLC (0.93%), RK Capital Management LLC (0.91%) and WINTON GROUP Ltd (0.83%). Company insiders that own Joint stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Peter D Holt and Ronald V Davella.
View institutional ownership trends for Joint

Which institutional investors are selling Joint stock?

JYNT stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Nuveen Asset Management LLC, Trexquant Investment LP, AQR Capital Management LLC, Engineers Gate Manager LP, Bridgeway Capital Management Inc., and UBS Group AG.
View insider buying and selling activity for Joint

Which institutional investors are buying Joint stock?

JYNT stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., RK Capital Management LLC, O Brien Greene & Co. Inc, Two Sigma Advisers LP, WINTON GROUP Ltd, PDT Partners LLC, SG Americas Securities LLC, and Bank of America Corp DE. Company insiders that have bought Joint stock in the last two years include Bandera Partners Llc, Jake Singleton, James H Amos Jr, and Peter D Holt.
View insider buying and selling activity for Joint

How do I buy shares of Joint?

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Joint's stock price today?

One share of JYNT stock can currently be purchased for approximately $17.75.

How big of a company is Joint?

Joint has a market capitalization of $248.70 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe.

What is Joint's official website?

The official website for Joint is www.thejoint.com.

How can I contact Joint?

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.